Dr. Brian H. Kopell, MD

Dr. Kopell practices at Mount Sinai West in New York, New York, part of Mount Sinai Health System.

Dr. Kopell's NPI, 1568413300, was assigned on May 15, 2006. Dr. Kopell graduated from New York University School of Medicine in 1996. Dr. Kopell's Wisconsin license number on file is 47197.

Dr. Kopell's primary practice is Mount Sinai West, at 1000 Tenth Avenue, New York, NY 10019 in New York County. The practice phone is (212) 523-4000.

Dr. Kopell's primary practice is Mount Sinai West in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Kopell to 1 more home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kopell practices, 2 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Kopell's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Kopell is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Kopell's licenses on file in 6 states: Wisconsin, Florida, New York, New Jersey, Connecticut and Ohio.

Dmand AI lists craniotomy among the conditions Dr. Kopell treats.

CMS data shows 243 Medicare services from Dr. Kopell across 7 procedure codes in 2024, for 102 Medicare patients. Medicare paid $147,055 for them.

CMS counts 102 Medicare patients who saw Dr. Kopell in 2024. The largest group is 65 to 74, with 47 patients. 70% of them have parkinson's disease, and 68% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kopell's median patient age at 65, with 31% women.

In 2017, Dr. Kopell wrote 38 Medicare Part D claims. They cover 2 drugs, with $250 in total drug cost. In 2016, CMS named 56 claims across 2 drugs.

Dr. Kopell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kopell as offering telehealth.

Dmand AI links 83 papers to Dr. Kopell, published from 2007 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Deep Brain Stimulation, Parkinson Disease and Brain. Dr. Kopell has published most often in World Neurosurg. Dr. Kopell's most frequent co-authors are Martijn Figee, MD, PhD, Helen Susan Mayberg, MD and Wayne K. Goodman, MD.

Dmand AI links Dr. Kopell to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Depressive Disorder, Treatment-Resistant, Obsessive-Compulsive Disorder and Anxiety Disorders.

CMS Open Payments shows 513 general payments to Dr. Kopell from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Abbott Laboratories paid the most, $98,105.

Dmand AI lists 1 award for Dr. Kopell, most recently CMS Stage 1 EHR in 2013. Dr. Kopell serves on Board of Directors American Society for Stereotactic and Functional Neurosurgery.

Dr. Kopell graduated from New York University School of Medicine in 1996. Dr. Kopell is a member of AOA, AANS, ASSFN and CNS.

Dr. Kopell is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.